 | • レポートコード：QYR2104Z3891 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、感染症検査における分子診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術（INAAT）、マイクロアレイ、次世代シーケンシング（NGS）、ハイブリダイゼーション、その他）、用途別市場規模（病院、クリニック、学術機関、研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・感染症検査における分子診断の市場動向 ・企業の競争状況、市場シェア ・感染症検査における分子診断の種類別市場規模（ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術（INAAT）、マイクロアレイ、次世代シーケンシング（NGS）、ハイブリダイゼーション、その他） ・感染症検査における分子診断の用途別市場規模（病院、クリニック、学術機関、研究所、その他） ・感染症検査における分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・感染症検査における分子診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・感染症検査における分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・感染症検査における分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・感染症検査における分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、BD、BioMerieux、Thermo Fisher Scientific、Roche、Siemens、Veridex、Luminex、GenMark Diagnostics、Qiagen、Genomix Biotech、BioTheranostics） ・結論 |
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.
North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.
Market Analysis and Insights: Global Molecular Diagnostics in Infectious Disease Testing Market
The global Molecular Diagnostics in Infectious Disease Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics in Infectious Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnostics in Infectious Disease Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnostics in Infectious Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnostics in Infectious Disease Testing market.
Global Molecular Diagnostics in Infectious Disease Testing Scope and Market Size
Molecular Diagnostics in Infectious Disease Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics in Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
Segment by Application
Hospitals
Clinics
Academic Institutes
Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
BD
BioMerieux
Thermo Fisher Scientific
Roche
Siemens
Veridex
Luminex
GenMark Diagnostics
Thermo Fisher Scientific
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.4 Microarrays
1.2.5 Next-Generation Sequencing (NGS)
1.2.6 Hybridization
1.2.7 Others
1.3 Market by Application
1.3.1 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic Institutes
1.3.5 Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Perspective (2016-2027)
2.2 Molecular Diagnostics in Infectious Disease Testing Growth Trends by Regions
2.2.1 Molecular Diagnostics in Infectious Disease Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Diagnostics in Infectious Disease Testing Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Diagnostics in Infectious Disease Testing Industry Dynamic
2.3.1 Molecular Diagnostics in Infectious Disease Testing Market Trends
2.3.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue (2016-2021)
3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics in Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Infectious Disease Testing Revenue in 2020
3.5 Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Type (2016-2021)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2022-2027)
5 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Application (2016-2021)
5.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size (2016-2027)
6.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type
6.2.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021)
6.2.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027)
6.2.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2027)
6.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application
6.3.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021)
6.3.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027)
6.3.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2027)
6.4 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country
6.4.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021)
6.4.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2016-2027)
7.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type
7.2.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021)
7.2.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027)
7.2.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2027)
7.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application
7.3.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021)
7.3.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027)
7.3.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2027)
7.4 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country
7.4.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021)
7.4.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size (2016-2027)
8.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size (2016-2027)
9.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type
9.2.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2027)
9.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application
9.3.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2027)
9.4 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country
9.4.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size (2016-2027)
10.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Introduction
11.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics in Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.2.5 BD Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Introduction
11.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.3.5 BioMerieux Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Introduction
11.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Siemens
11.6.1 Siemens Company Details
11.6.2 Siemens Business Overview
11.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Introduction
11.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.6.5 Siemens Recent Development
11.7 Veridex
11.7.1 Veridex Company Details
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.7.5 Veridex Recent Development
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.8.5 Luminex Recent Development
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Details
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.9.5 GenMark Diagnostics Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Introduction
11.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.10.5 Qiagen Recent Development
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Details
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.11.5 Genomix Biotech Recent Development
11.12 BioTheranostics
11.12.1 BioTheranostics Company Details
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.12.5 BioTheranostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 4. Key Players of Microarrays
Table 5. Key Players of Next-Generation Sequencing (NGS)
Table 6. Key Players of Hybridization
Table 7. Key Players of Others
Table 8. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2016-2021)
Table 12. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2022-2027)
Table 14. Molecular Diagnostics in Infectious Disease Testing Market Trends
Table 15. Molecular Diagnostics in Infectious Disease Testing Market Drivers
Table 16. Molecular Diagnostics in Infectious Disease Testing Market Challenges
Table 17. Molecular Diagnostics in Infectious Disease Testing Market Restraints
Table 18. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players (2016-2021)
Table 20. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2020)
Table 21. Ranking of Global Top Molecular Diagnostics in Infectious Disease Testing Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
Table 25. Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2016-2021)
Table 29. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Molecular Diagnostics in Infectious Disease Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2016-2021)
Table 33. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 65. Abbott Company Details
Table 66. Abbott Business Overview
Table 67. Abbott Molecular Diagnostics in Infectious Disease Testing Product
Table 68. Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 69. Abbott Recent Development
Table 70. BD Company Details
Table 71. BD Business Overview
Table 72. BD Molecular Diagnostics in Infectious Disease Testing Product
Table 73. BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 74. BD Recent Development
Table 75. BioMerieux Company Details
Table 76. BioMerieux Business Overview
Table 77. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product
Table 78. BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 79. BioMerieux Recent Development
Table 80. Thermo Fisher Scientific Company Details
Table 81. Thermo Fisher Scientific Business Overview
Table 82. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product
Table 83. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 84. Thermo Fisher Scientific Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Molecular Diagnostics in Infectious Disease Testing Product
Table 88. Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 89. Roche Recent Development
Table 90. Siemens Company Details
Table 91. Siemens Business Overview
Table 92. Siemens Molecular Diagnostics in Infectious Disease Testing Product
Table 93. Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 94. Siemens Recent Development
Table 95. Veridex Company Details
Table 96. Veridex Business Overview
Table 97. Veridex Molecular Diagnostics in Infectious Disease Testing Product
Table 98. Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 99. Veridex Recent Development
Table 100. Luminex Company Details
Table 101. Luminex Business Overview
Table 102. Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 103. Luminex Recent Development
Table 104. GenMark Diagnostics Company Details
Table 105. GenMark Diagnostics Business Overview
Table 106. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product
Table 107. GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 108. GenMark Diagnostics Recent Development
Table 109. Qiagen Company Details
Table 110. Qiagen Business Overview
Table 111. Qiagen Molecular Diagnostics in Infectious Disease Testing Product
Table 112. Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 113. Qiagen Recent Development
Table 114. Genomix Biotech Company Details
Table 115. Genomix Biotech Business Overview
Table 116. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product
Table 117. Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 118. Genomix Biotech Recent Development
Table 119. BioTheranostics Company Details
Table 120. BioTheranostics Business Overview
Table 121. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product
Table 122. BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 123. BioTheranostics Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type: 2020 VS 2027
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Isothermal Nucleic Acid Amplification Technology (INAAT) Features
Figure 4. Microarrays Features
Figure 5. Next-Generation Sequencing (NGS) Features
Figure 6. Hybridization Features
Figure 7. Others Features
Figure 8. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Academic Institutes Case Studies
Figure 12. Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Molecular Diagnostics in Infectious Disease Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions: 2020 VS 2027
Figure 18. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2022-2027)
Figure 19. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players in 2020
Figure 20. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2020
Figure 22. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2016-2021)
Figure 23. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2022-2027)
Figure 24. North America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2016-2027)
Figure 26. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2016-2027)
Figure 27. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2016-2027)
Figure 28. United States Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2016-2027)
Figure 32. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2016-2027)
Figure 33. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2016-2027)
Figure 34. Germany Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2016-2027)
Figure 44. China Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2016-2027)
Figure 52. Latin America Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2016-2027)
Figure 53. Latin America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2016-2027)
Figure 54. Mexico Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2016-2027)
Figure 60. Turkey Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Abbott Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 64. BD Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 65. BioMerieux Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 67. Roche Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 68. Siemens Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 69. Veridex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 70. Luminex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 71. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 72. Qiagen Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 73. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 74. BioTheranostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の感染症検査市場規模・現状・予測（2021年-2027年） In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection. Biochemical tests used in th…- 世界の等温核酸増幅技術（INAAT）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market The global Isothermal Nucleic Acid Amplification Technology (INAAT) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indu…
- 世界の感染症診断検査市場規模・現状・予測（2021年-2027年） In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection. Biochemical tests used in th…
- 世界の感染症用ポイントオブケア検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Point of Care Testing for Infectious Disease Market The global Point of Care Testing for Infectious Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の感染症検査・診断市場規模・現状・予測（2021年-2027年） Infectious disease testing is the process of identification of causative organisms for the primary diagnosis of diseases. Market Analysis and Insights: Global Infectious Disease Testing And Diagnostic Market The global Infectious Disease Testing And Diagnostic market size is projected to reach US$ X…